Arizona State Retirement System Has $39.11 Million Stock Holdings in Danaher Corporation (NYSE:DHR)

Arizona State Retirement System raised its holdings in shares of Danaher Corporation (NYSE:DHR - Free Report) by 1.4% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 190,771 shares of the conglomerate's stock after purchasing an additional 2,565 shares during the quarter. Arizona State Retirement System's holdings in Danaher were worth $39,108,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in the business. FAS Wealth Partners Inc. lifted its holdings in shares of Danaher by 20.6% during the fourth quarter. FAS Wealth Partners Inc. now owns 9,597 shares of the conglomerate's stock worth $2,203,000 after buying an additional 1,639 shares in the last quarter. Horizon Financial Services LLC lifted its holdings in shares of Danaher by 20,400.0% during the first quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate's stock worth $1,681,000 after buying an additional 8,160 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of Danaher by 11.4% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,677,032 shares of the conglomerate's stock worth $1,303,163,000 after buying an additional 579,046 shares in the last quarter. Compass Wealth Management LLC lifted its holdings in shares of Danaher by 17.4% during the first quarter. Compass Wealth Management LLC now owns 39,764 shares of the conglomerate's stock worth $8,152,000 after buying an additional 5,891 shares in the last quarter. Finally, Terra Alpha Investments LLC acquired a new stake in shares of Danaher during the fourth quarter worth $3,068,000. Institutional investors and hedge funds own 79.05% of the company's stock.

Insider Activity at Danaher

In other Danaher news, EVP Christopher Paul Riley sold 15,805 shares of the business's stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total value of $3,129,390.00. Following the transaction, the executive vice president directly owned 15,179 shares of the company's stock, valued at approximately $3,005,442. The trade was a 51.01% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Chairman Steven M. Rales sold 1,250,000 shares of the business's stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $196.74, for a total value of $245,925,000.00. Following the completion of the transaction, the chairman directly owned 3,105,808 shares in the company, valued at approximately $611,036,665.92. This trade represents a 28.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.10% of the stock is currently owned by insiders.

Danaher Price Performance

Danaher stock opened at $204.80 on Friday. The stock's 50 day moving average is $196.05 and its 200 day moving average is $206.47. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.43 and a quick ratio of 1.05. The firm has a market cap of $146.57 billion, a P/E ratio of 39.77, a P/E/G ratio of 2.89 and a beta of 0.77. Danaher Corporation has a one year low of $171.00 and a one year high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, topping analysts' consensus estimates of $1.62 by $0.26. The company had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.58 billion. Danaher had a return on equity of 10.80% and a net margin of 15.81%. As a group, research analysts expect that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be paid a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.63%. Danaher's dividend payout ratio (DPR) is presently 24.85%.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on DHR. Leerink Partners lifted their target price on Danaher from $225.00 to $230.00 and gave the stock an "outperform" rating in a report on Wednesday, April 23rd. Bank of America decreased their price target on Danaher from $265.00 to $230.00 in a research report on Monday, April 14th. Guggenheim restated a "buy" rating and issued a $250.00 price target on shares of Danaher in a research report on Wednesday, April 23rd. UBS Group decreased their price target on Danaher from $275.00 to $240.00 and set a "buy" rating on the stock in a research report on Wednesday, April 23rd. Finally, Scotiabank upgraded Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 price target on the stock in a research report on Friday. Three equities research analysts have rated the stock with a hold rating and eighteen have given a buy rating to the company. According to data from MarketBeat, Danaher has an average rating of "Moderate Buy" and a consensus price target of $248.43.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.